Harvard Science News 2025 | HMS Top Stories

Harvard Medical School Research Dominates 2025’s Breakthroughs in Health and Human Biology

Despite unprecedented challenges facing research and higher education,Harvard medical School (HMS) scientists continued to spearhead groundbreaking discoveries in 2025,pushing the boundaries of biomedical science and healthcare delivery. studies conducted at HMS and its affiliated hospitals – often in collaboration with leading institutions and biopharmaceutical companies – deepened our understanding of human biology, illuminated the mechanisms of both common and rare diseases, and contributed to the development of innovative treatments and diagnostic tools. Here are the ten most-read news stories detailing HMS-led discoveries from the past year.

Could Lithium explain – and Treat – Alzheimer’s Disease?

Researchers at HMS revealed a surprising connection between lithium and Alzheimer’s disease, demonstrating for the first time that lithium naturally occurs in the brain and offers protection against neurodegeneration. Conversely, they found that a loss of lithium in the brain is one of the earliest indicators of Alzheimer’s, with similar depletion in mice accelerating brain pathology and memory decline. The team also identified a novel lithium compound that successfully restored memory function in mouse models. “My hope is that lithium will do somthing more basic than anti-amyloid or anti-tau therapies, not just lessening but reversing cognitive decline and improving patients’ lives,” said a senior author of the study. The findings, published in Nature, offer a new theory of the disease and a promising strategy for early diagnosis, prevention, and treatment.

Private Equity Acquisitions Linked to Increased Emergency Room Mortality

A nationwide study conducted by researchers at HMS, the University of Pittsburgh, and the University of Chicago revealed a disturbing trend: patient death rates increased in emergency departments of U.S. hospitals after being acquired by private equity firms. The study also found meaningful cuts in staffing and salaries at these acquired hospitals compared to similar, non-acquired institutions. “Among Medicare patients, who are frequently enough older and more vulnerable, this study shows that those financial strategies [of staffing cuts] may led to perhaps dangerous, even deadly consequences,” stated a senior author of the research, published in Annals of Internal Medicine. The findings provide concrete evidence that the for-profit ownership model of healthcare can have dire consequences for patient safety.

Ancient DNA Unlocks the Origins of Indo-European Languages

An international collaboration involving HMS researchers genetically pinpointed the originators of the vast Indo-European language family, encompassing over 400 languages.Building on decades of linguistic,archaeological,and genetic research,the studies confirmed the “steppe hypothesis,” placing the birthplace of these languages on the Eurasian steppe – the region encompassing modern-day Russia and Ukraine. “It’s the first time we have a genetic picture unifying all Indo-European languages,” explained a co-first author of the study,published in Nature. The research considerably enriches our understanding of human population history and interconnectedness.

Huntington’s Disease: New Insights into Delayed Symptom Onset

Scientists at HMS, the Broad Institute of MIT and Harvard, and mclean Hospital uncovered why symptoms of Huntington’s disease typically don’t appear until midlife, despite patients being born with the genetic mutation. Their analysis revealed that the repeated DNA sequence driving the disease expands slowly over decades in specific brain cells before rapidly lengthening and causing cell death. “it’s only when the repeat becomes extremely long that it begins to cause harm. This is a really different way of thinking not only about how Huntington’s disease develops but also about how a mutation brings about a diseas

Gut Motility, Inflammation, and a Novel Protein Target

Researchers at HMS and Massachusetts General Hospital have identified a key protein that regulates gut motility and inflammation. They discovered that gut motility is influenced by exercise, pressure, and inflammation, and that a pressure-sensing protein called PIEZO1 coordinates intestinal movements and helps regulate inflammation. “Eventually, we might stimulate PIEZO1 to speed up excretion, block it to treat diarrhea, or use it as a novel target to treat intestinal inflammation in inflammatory bowel disease patients,” said a co-senior author, with the study published in Cell.